Literature DB >> 8926619

Expression of IL-8, TNF-alpha and IFN-gamma m-RNA in ulcerative colitis, particularly in patients with inactive phase.

H Masuda1, S Iwai, T Tanaka, S Hayakawa.   

Abstract

OBJECTIVE: The etiology of ulcerative colitis (UC) remains uncertain. It has been said that in patients with an active phase of UC the levels of the proinflammatory cytokines increased. Paying particular attention to patients with inactive UC, we investigated several cytokines' m-RNA transcripts.
METHODS: In 27 patients with UC, the mucosal cytokine expression of m-RNA including IL-8, TNF-alpha, IFN-gamma and IL-6 were examined using the reverse transcription-coupled polymerase chain reaction (RT-PCR) and oligonucleotide hybridization.
RESULTS: 1) The expression ratios of m-RNA of IL-8, IFN-gamma and TNF-alpha in cases with UC (92.6%, 70.4% and 77.8%, respectively) were significantly higher than in normal controls (17.6%, 0.0% and 5.9%, respectively) (p < 0.01). Regarding IL-8 and IFN-gamma, those in UC cases were also significantly higher than in cases with other types of colitis (p < 0.05). 2) No significant difference was noted between active and inactive cases with UC in terms of the expression ratios of m-RNA of IL-8, TNF-alpha and IFN-gamma. 3) Only the expression ratio of IL-6 m-RNA correlated with the macroscopic score according to Matts. In addition, expression of IL-6 m-RNA in the colon tissue was observed in 9 out of 10 cases with other types of colitis (90.0%).
CONCLUSION: The expression of IL-8, TNF-alpha and IFN-gamma m-RNA increased even in inactive UC, suggesting that these three cytokines play an important role in the pathogenesis of repeated inflammation of UC.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8926619

Source DB:  PubMed          Journal:  J Clin Lab Immunol        ISSN: 0141-2760


  18 in total

Review 1.  Anti-tumour necrosis factor therapy for ulcerative colitis: evidence to date.

Authors:  Chandrashekhar Thukral; Adam Cheifetz; Mark A Peppercorn
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  Profiling of ABC transporters during active ulcerative colitis and in vitro effect of inflammatory modulators.

Authors:  Nirmal Verma; Vineet Ahuja; Jaishree Paul
Journal:  Dig Dis Sci       Date:  2013-03-20       Impact factor: 3.199

Review 3.  Gut Microbiota, Inflammation, and Colorectal Cancer.

Authors:  Caitlin A Brennan; Wendy S Garrett
Journal:  Annu Rev Microbiol       Date:  2016-09-08       Impact factor: 15.500

Review 4.  Intestinal inflammation and the diet: Is food friend or foe?

Authors:  Bryant W Megna; Patrick R Carney; Gregory D Kennedy
Journal:  World J Gastrointest Surg       Date:  2016-02-27

Review 5.  Advances in treatment of ulcerative colitis with herbs: from bench to bedside.

Authors:  Ping Wan; Hao Chen; Yuan Guo; Ai-Ping Bai
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

6.  Measurement of in vivo rectal mucosal cytokine and eicosanoid production in ulcerative colitis using filter paper.

Authors:  E Carty; M De Brabander; R M Feakins; D S Rampton
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

7.  Novel Colitis Immunotherapy Targets Bin1 and Improves Colon Cell Barrier Function.

Authors:  Sunil Thomas; Joanna M Mercado; James DuHadaway; Kate DiGuilio; James M Mullin; George C Prendergast
Journal:  Dig Dis Sci       Date:  2015-07-21       Impact factor: 3.199

8.  Alcohol enhances symptoms and propensity for infection in inflammatory bowel disease patients and a murine model of DSS-induced colitis.

Authors:  Abigail R Cannon; Paulius V Kuprys; Adrienne N Cobb; Xianzhong Ding; Anai N Kothari; Paul C Kuo; Joshua M Eberhardt; Adam M Hammer; Niya L Morris; Xiaoling Li; Mashkoor A Choudhry
Journal:  J Leukoc Biol       Date:  2018-05-18       Impact factor: 4.962

9.  Neonatal Injury Increases Gut Permeability by Epigenetically Suppressing E-Cadherin in Adulthood.

Authors:  Kevin T Kline; Haifeng Lian; Xiaoying S Zhong; Xiuju Luo; John H Winston; Yingzi Cong; Tor C Savidge; Roderick H Dashwood; Don W Powell; Qingjie Li
Journal:  J Immunol       Date:  2019-12-30       Impact factor: 5.422

10.  Interleukin-8 producing hepatocellular carcinoma with pyrexia.

Authors:  Norifumi Harimoto; Ken Shirabe; Tomoyuki Abe; Kiyoshi Kajiyama; Takashi Nagaie; Tomonobu Gion; Yousuke Kuroda; Yoshihiko Maehara
Journal:  HPB Surg       Date:  2009-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.